tiprankstipranks
Trending News
More News >
Blueprint Medicines (BPMC)
NASDAQ:BPMC

Blueprint Medicines (BPMC) Revenue

Compare
591 Followers

Blueprint Medicines Revenue

Blueprint Medicines had a revenue of 149.41M in the quarter ending Mar 31, 2025, with 2.08%. This bring the company's revenue in the last twelve months to 562.12M, Decreased 10.47%. In the fiscal year ending Dec 31, 2024, Blueprint Medicines had annual revenue of 508.82M with 104.04% growth.
Revenue (ttm)
562.12M
Revenue Growth
99.19%
P/S Ratio
12.86
Revenue/Employee
$746,076
Employees
682
Market Cap
$6.55B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
508.82M259.44M+104.04%
Dec 31, 2023
249.38M45.34M+22.22%
Dec 31, 2022
204.04M23.96M+13.30%
Dec 31, 2021
180.08M-613.65M-77.31%
Dec 31, 2020
793.74M727.22M+1,093.37%
Dec 31, 2019
66.51M21.99M+49.39%
Dec 31, 2018
44.52M23.09M+107.79%
Dec 31, 2017
21.43M-6.35M-22.85%
Dec 31, 2016
27.77M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis